Performance analysis of Citius Pharmaceuticals (CTXR)
Annual Return
Over the past 3 years, CTXR has had an average annual return of -74.54%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, CTXR has had an average annual return of -60.42%, underperforming the benchmark SPY, which returned +12.55% annual.
Since Jul 6, 2017, CTXR has had an average annual return of -47.02%, underperforming the benchmark SPY, which returned +15.04% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.25% | -80.53% | -78.87% | -4.25% | -48.71% | +51.02% | -0% | -1.94% | -72.63% | -37.70% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.92% | +0% | +20.41% | -22.03% | -6.52% | -6.98% | -20.00% | -37.25% | |||||
| 2025 | -32.82% | -38.64% | -9.26% | -48.98% | -10.00% | +131.11% | -13.46% | -3.33% | -6.90% | +28.40% | -9.62% | -45.74% | -80.53% |
| 2024 | -17.90% | +23.77% | +16.75% | -16.86% | -6.54% | -16.27% | +55.07% | -37.06% | -12.10% | -25.58% | -64.32% | +20.18% | -78.87% |
| 2023 | +75.98% | -17.29% | +1.75% | +23.93% | -19.98% | +3.42% | -17.49% | -7.89% | -24.95% | +9.98% | +2.43% | -1.90% | -4.25% |
| 2022 | -1.98% | +2.02% | +16.20% | -43.56% | -7.00% | -2.08% | -2.92% | +37.70% | -1.59% | -10.79% | +8.36% | -32.48% | -48.71% |
| 2021 | +19.62% | +66.40% | -12.32% | +23.61% | +3.63% | +52.62% | -45.70% | +19.08% | -9.79% | -7.87% | -9.65% | -8.84% | +51.02% |
| 2020 | +15.67% | -39.66% | -15.68% | +53.15% | -5.57% | +30.15% | +14.20% | -27.90% | +11.80% | -5.75% | +5.10% | -1.01% | -0% |
| 2019 | -7.68% | +27.70% | +15.82% | -27.45% | +13.56% | -16.21% | +37.71% | -24.45% | -25.66% | -28.80% | -14.80% | +121.75% | -1.94% |
| 2018 | +12.36% | -19.44% | -9.88% | -18.38% | +6.08% | -14.32% | +8.28% | -38.56% | +11.76% | -15.20% | -19.31% | -11.11% | -72.63% |
| 2017 | -14.26% | -33.08% | -9.93% | +7.86% | +48.82% | -24.89% | -37.70% |
Drawdown analysis of Citius Pharmaceuticals (CTXR)
The maximum drawdown for the CTXR was -99.69%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current CTXR drawdown is -99.69%.
Since Jul 6, 2017 CTXR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.69% | Jul 12, 2017 | 2266 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -1.93% | Jul 10, 2017 | 1 | Jul 11, 2017 | 1 | Jul 12, 2017 | 2 |